Crescent Biopharma
CBIO
CBIO
12.58
USD
-0.33
2.56%
At close
Updated
Oct 14, 4:00 PM EDT
Pre-market
After hours
12.58
0.00
0%
1 day
-2.56%
5 days
-6.05%
1 month
-36.08%
3 months
-17.83%
6 months
-35.55%
Year to date
13.54%
1 year
21.08%
5 years
-93.8%
10 years
-97.9%
New
Increased
Maintained
Reduced
Closed
Mega AUM
Over $200B
Large AUM
$10B to $200B
Mid AUM
$2B to $10B
Small AUM
$250M to $2B
Micro AUM
Under $250M
Less than 10%
Less than 20%
Less than 40%
Less than 60%
Less than 80%
| # | Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|---|
| 26 |
26
UBS Group
Zurich,
Switzerland
| $16K | +$7.45K | +9 | +82% |
|
| 27 |
27
Acadian Asset Management
Boston,
Massachusetts
| $14K | – | – | – |
|
| 28 |
BIM
28
BlackRock Investment Management
Wilmington,
Delaware
| $13K | +$2.48K | +3 | +23% |
|
| 29 |
GC
29
Globeflex Capital
San Diego,
California
| $1K | – | – | – |
|
| 30 |
TCOV
30
Trust Company of Vermont
Brattleboro,
Vermont
| $1K | – | – | – |
|
| 31 |
31
Federated Hermes
Pittsburgh,
Pennsylvania
| $1K | +$827 | +1 | New |
|
| 32 |
32
JP Morgan Chase
New York
| – | -$628K | -755 | Closed |
|